Show simple item record

COVID‐19 infection in former living kidney donors

dc.contributor.authorDoshi, Mona D.
dc.contributor.authorTsapepas, Demetra
dc.contributor.authorPrashar, Rohini
dc.contributor.authorMohan, Sumit
dc.contributor.authorEdusei, Emmanuel
dc.contributor.authorAull, Meredith J.
dc.contributor.authorSherman, Eric
dc.contributor.authorDadhania, Darshana M.
dc.date.accessioned2021-05-12T17:26:55Z
dc.date.available2022-05-12 13:26:54en
dc.date.available2021-05-12T17:26:55Z
dc.date.issued2021-04
dc.identifier.citationDoshi, Mona D.; Tsapepas, Demetra; Prashar, Rohini; Mohan, Sumit; Edusei, Emmanuel; Aull, Meredith J.; Sherman, Eric; Dadhania, Darshana M. (2021). "COVID‐19 infection in former living kidney donors." Clinical Transplantation (4): n/a-n/a.
dc.identifier.issn0902-0063
dc.identifier.issn1399-0012
dc.identifier.urihttps://hdl.handle.net/2027.42/167537
dc.description.abstractThe COVID‐19 pandemic brought living donor kidney transplant programs across the United States to a near halt in March 2020. As programs have begun to reopen, potential donor candidates often inquire about their risk of a COVID‐19 infection and its potential impact on kidney function after donation. To address their concerns, we surveyed 1740 former live kidney donors at four transplant centers located in New York and Michigan. Of these, 839 (48.2%) donors responded, their mean age was 46 ± 12.5 years, 543 (65%) were females, and 611 (73%) were white. Ninety‐two donors (11%) had symptoms suggestive of a COVID‐19 infection with fever (48%) and fatigue (43%) being the most common. Among those with symptoms, 42 donors underwent testing and 16 tested positive. Testing was more common among donors with private insurance, and a positive test result was more common among young black donors. Only one donor surveyed required hospitalization and none required dialysis. Fourteen donors have recovered completely and two partially. Our survey highlights that a COVID‐19 infection in former donors results in a mild disease with good recovery. These data will be useful for transplant programs to counsel living donors who are considering kidney donation during this pandemic.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherinfection
dc.subject.otheroutcomes
dc.subject.otherliving kidney donors
dc.subject.otherCOVID‐19
dc.titleCOVID‐19 infection in former living kidney donors
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/167537/1/ctr14230.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/167537/2/ctr14230_am.pdf
dc.identifier.doi10.1111/ctr.14230
dc.identifier.sourceClinical Transplantation
dc.identifier.citedreferenceBoehmer TK, DeVies J, Caruso E, et al. Changing age distribution of the COVID‐19 pandemic – United States, may‐august 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 ( 39 ): 1404 ‐ 1409.
dc.identifier.citedreferenceMillett GA, Jones AT, Benkeser D, et al. Assessing differential impacts of COVID‐19 on black communities. Ann Epidemiol. 2020; 47: 37 ‐ 44.
dc.identifier.citedreferencehttps://www.whitehouse.gov/presidential-actions/proclamation-declaring-national-emergency-concerning-novel-coronavirus-disease-covid-19-outbreak/; 2020.
dc.identifier.citedreferenceBoyarsky BJ, Po‐Yu Chiang T, Werbel WA, et al. Early impact of COVID‐19 on transplant center practices and policies in the United States. Am J Transplant. 2020; 20 ( 7 ): 1809 ‐ 1818.
dc.identifier.citedreferenceLentine KL, Vest L, Schnitzler MA, et al. Survey of U.S. living kidney donation and transplant practices in the COVID‐19 era. Kidney Int Rep. 2020. 5 ( 11 ): 1894 – 1905.
dc.identifier.citedreferenceAmerican Society of Transplantation (AST). 2019‐nCoV (Coronavirus): Recommendations and Guidance for Organ Donor Testing. Updated May 19, 2020. Available at Accessed Updated May 19, 2020; 2020.
dc.identifier.citedreferenceAmerican Society of Transplant Surgeons (ASTS). Re‐engaging Organ Transplantation in the COVID‐19 Era. June 5, 2020. Accessed.
dc.identifier.citedreferenceHirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID‐19. Kidney Int. 2020; 98 ( 1 ): 209 ‐ 218.
dc.identifier.citedreferenceLee JR, Silberzweig J, Akchurin O, et al. Characteristics of acute kidney injury in hospitalized COVID‐19 patients in an urban academic medical center. Clin J Am Soc Nephrol. 2020. https://doi.org/10.2215/CJN.07440520
dc.identifier.citedreferenceNimkar A, Naaraayan A, Hasan A, et al. Incidence and risk factors for acute kidney injury and its effect on mortality in patients hospitalized from Covid‐19. Mayo Clin Proc Innov Qual Outcomes. 2020; 4 ( 6 ): 687 ‐ 695.
dc.identifier.citedreferenceHarhay M, Klassen A, Fleetwood J, et al. Living organ donor perspectives on organ donation during the COVID‐19 pandemic. J Am Soc Nephrol. 2020;Kidney Week Edition( 31 ): 277.
dc.identifier.citedreferencePascarella G, Strumia A, Piliego C, et al. COVID‐19 diagnosis and management: a comprehensive review. J Intern Med. 2020; 288 ( 2 ): 192 ‐ 206.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.